Latest Low-density lipoprotein Stories
Achievement of LDL Particle Targets Associated with More Aggressive Lipid-lowering Therapy and Better Clinical Outcomes Compared to Patients Managed to LDL Cholesterol Targets RALEIGH,
Loss-of-function mutations in APOC3 gene lower blood lipids and lower risk of coronary artery disease CAMBRIDGE, Mass., June 18, 2014 /PRNewswire/ -- By scouring the DNA of thousands
Canola is Canada's oil and new research from St. Michael's Hospital suggests it should also be one of the oils of choice for people with Type 2 diabetes.
New guidelines for the treatment of high cholesterol are not appropriate for people with type 2 diabetes – or are they?
Data Presented at ADA Scientific Sessions Suggest DRI May Enable More Timely and Focused Risk Assessment and Intervention in At-risk Patients SAN FRANCISCO, June 14, 2014 /PRNewswire/ --
INDIANAPOLIS, June 10, 2014 /PRNewswire/ -- Chek Diagnostics, the U.S.-based manufacturer of both the CardioChek® brand and the A1CNow® family of point-of-care diagnostic products, announced
Advances in the understanding of the genetics of coronary artery disease, or CAD, will revitalize the field and lead to more therapeutic targets for new medicines to combat this common disease.
LEXINGTON, Mass., June 3, 2014 /PRNewswire/ -- Synageva BioPharma Corp. (Synageva) (NASDAQ: GEVA), a biopharmaceutical company
Save 10% on Men's Health Testing from Request A Test through June 30th, 2014.
Data From Phase 3 TESLA Study in Patients With Homozygous Familial Hypercholesterolemia (HoFH) and Phase 2/3 TAUSSIG Study in Patients With Severe Familial Hypercholesterolemia Presented in Late-Breaking
- The word or words serving to define another word or expression, as in a dictionary entry.